gvtcx

709673452 - Supply of Obiltoxaximab Treatment RFI

Ministry of Defence Published 2 Nov 2023 Contracts Finder

key details

Statusplanning
Category (CPV) 33600000
RegionSouth West
SME suitableYes
OCIDocds-b5fd17-9aa81cbc-40c2-47e6-b475-e52cbc9dd5f5

description

The Ministry of Defence (MOD) are considering a requirement to procure UK/EU Licensed Obiltoxaximab Treatment as soon as is technically possible.

To inform this requirement, the MOD seek information in response to the following:

a.Whether it is possible to supply a UK/EU Licensed Obiltoxaximab
b.If there is a minimum order quantity
c.What price breaks apply, if any.
d.Evidence of UK/EU Licensing
e.Is this product commercially available off-the-shelf (COTS)
f.Indicative pricing
g.Lead times

In addition to confirming whether the above requirements can be met, the following information is required:

  1. Licensing status to include GMP/GDP/GLP/GCP in country of origin and any other licensing restrictions that may apply.

The MOD is only seeking information from industry at this stage on availability and basic technical information of potential UK/EU Licensed Obiltoxaximab Treatment that meet or exceed the requirements listed above.

Submissions with product data sheets are initially invited. Promising and appropriate responses may be followed up by a meeting to discuss the requirement further.

The RFI is without commitment and is subject to contract.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
2 Nov 2023 Planning (planning) · df63928d-2eba-4a6b-b2e8-81205cb0c110-694345

more from Ministry of Defence

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.